Product Information
FIRVANQ 50 MG/ML SOLUTION is a brand product labeled by Azurity Pharmaceuticals Inc., priced at $1.1860 per ML under NDC 65628020605. Its NADAC has been published 380 times since Aug 22, 2018.
Manufacturer
Azurity Pharmaceuticals Inc.NDC
65628020605
Classification
Brand
Dosage Form
KIT
Last Updated
1/1/2026
Approval Type
New Drug (NDA)
FDA Application
NDA208910On Market Since
1/26/2018
Price Statistics
The NADAC for FIRVANQ 50 MG/ML SOLUTION has been published 380 times since Aug 22, 2018, and over the history we have for it it has risen 47.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.1860 per ML |
|---|---|
| All-time high | $1.1860 (Jun 24, 2026) |
| All-time low | $0.8030 (Aug 22, 2018) |
| 52-week high | $1.1860 |
| 52-week low | $1.1353 |
| Median price | $0.9201 |
| Average price | $0.9544 |
| Largest weekly change | +11.3% (Jun 19, 2024) |
| Weeks tracked | 380 |
| Tracking since | Aug 22, 2018 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 66% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of FIRVANQ 50 MG/ML SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for FIRVANQ 50 MG/ML SOLUTION, manufactured by Azurity Pharmaceuticals Inc., is $1.1860 per ML (NDC 65628020605), effective Jun 24, 2026.
How has the price of FIRVANQ 50 MG/ML SOLUTION changed over time?
Over the history we have for it, the NADAC for FIRVANQ 50 MG/ML SOLUTION has risen 47.7%. It has been tracked across 380 weekly CMS publications since Aug 22, 2018.
What are the highest and lowest recorded NADAC prices for FIRVANQ 50 MG/ML SOLUTION?
Since Aug 22, 2018, the NADAC for FIRVANQ 50 MG/ML SOLUTION has ranged from a low of $0.8030 (Aug 22, 2018) to a high of $1.1860 (Jun 24, 2026), with a median of $0.9201 per ML.
Are there cheaper alternatives to FIRVANQ 50 MG/ML SOLUTION?
Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, VANCOMYCIN 25 MG/ML ORAL SOLN, is $0.4082 per ML — about 66% below FIRVANQ 50 MG/ML SOLUTION.
Who manufactures FIRVANQ 50 MG/ML SOLUTION?
FIRVANQ 50 MG/ML SOLUTION (NDC 65628020605) is labeled by Azurity Pharmaceuticals Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification